Although lowering eye pressure can help slow or stop glaucoma progression, there are currently no therapies to regenerate lost nerve cells and help patients that have already lost vision.
Every day, glaucoma researchers work to better understand and find safer, more effective ways to treat this debilitating disease.
Stem cell therapies are getting headlines for their potential to cure diseases, including those that affect vision. But an important message is missing: stem cell therapies are not yet proven to be safe and effective for your eyes.
Dr. Di Polo’s laboratory investigated the hypothesis that insulin can improve the survival and function of injured retinal ganglion cells and may be viable as an innovative glaucoma treatment.
For the first time, thanks to improvements in how we measure the disease, researchers are studying and testing new therapeutic candidates for neuroprotection, neuroenhancement, and visual restoration.
Listen to the 2018 Weston Glaucoma Research Lecture delivered by Jeffrey Goldberg, MD, PhD, a principal investigator in the Catalyst for a Cure.
New approaches to treating, managing, and even curing glaucoma are essential to patients and caregivers. Researchers are actively working to advance the field in several key areas.
Research outcomes from past Shaffer Grant recipients demonstrate the impact of this funding in catalyzing the growth, sustainability, and productivity of glaucoma research laboratories across the US.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
Print Subscription
We will mail Gleams anywhere in the United States and Canada, but we do not mail internationally. Please sign up for the email edition if you live outside of the US or Canada.
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
